ZEVRA THERAPEUTICS, INC. Income Statement
ZVRA|1 years of annual SEC 10-K data (FY2015-FY2015)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
ZEVRA THERAPEUTICS, INC. reported $0 in revenue and $5M in net loss for FY2015.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 |
|---|---|
| Revenue | $0 |
| SG&A Expense | $1.4M |
| R&D Expense | $3.4M |
| Operating Income | -$4.7M |
| Interest Expense | $157.0K |
| Income Tax | -$20.0K |
| Net Income | -$5.2M |
| EPS (Diluted) | -$2.20 |
| Shares Outstanding | 2.4M |